HK inno.N posts operating profit of 30.09 billion won in Q2 2026, up 53.6% from a year earlier

HK inno.N reported provisional Q2 2026 sales of KRW 267.2 billion, operating profit of KRW 30.0 billion, and net profit of KRW 13.7 billion.

Second-quarter operating profit rose 53.6% year on year, while first-half operating profit reached KRW 63.2 billion, up 40.7%.

The stronger profit growth may support investor sentiment and valuation for the KOSDAQ-listed pharmaceutical company.